Find Cancer Clinical Trials Across Leading Hospitals and Research Centers
Explore clinical trials by cancer type, treatment, mutation, country, hospital, or city. CancerFax helps patients and families understand trial options with clarity, caution, and expert coordination.
Clinical trials may offer access to promising therapies when standard treatment options are limited, unavailable, or no longer effective. We help patients explore suitable trials across advanced cancer centers โ especially for complex, relapsed, refractory, and mutation-specific cancers.
Search Cancer Clinical Trials Worldwide
Browse 200+ cancer clinical trials across leading research centres in China, India, USA, South Korea, and Singapore. Search by cancer type, treatment, mutation, phase, or biomarker.
Showing 0 clinical trials
Trial information is for educational purposes. Final eligibility must be confirmed by the treating hospital or trial investigator.
No trials found
Try different search terms or adjust the filters. You can also submit your medical reports for a personalised trial search by our team.
Submit ReportsExplore Clinical Trials by Treatment Type
Clinical trials are often organized around a treatment approach, cancer type, biomarker, or stage of disease. Patients can explore trials by therapy category to better understand which advanced options may be relevant.
CAR T-Cell Therapy Trials
For blood cancers and selected solid tumors, CAR T-cell therapy trials may be considered when standard treatments are no longer effective.
Explore trials โCAR-NK Cell Therapy Trials
CAR-NK trials are being explored for several advanced cancers, including selected solid tumors and blood cancers.
Explore trials โTIL Therapy Trials
TIL therapy trials may be relevant for selected patients with melanoma, cervical cancer, lung cancer, and other solid tumors.
Explore trials โTargeted Therapy Trials
Mutation-specific trials may be available for cancers with actionable alterations such as EGFR, ALK, HER2, KRAS, BRAF, RET, MET, and NTRK.
Explore trials โImmunotherapy Trials
Immunotherapy trials may include checkpoint inhibitors, bispecific antibodies, cancer vaccines, or combination approaches.
Explore trials โOncolytic Virus & Gene Therapy
Some trials explore virus-based or gene-based strategies designed to stimulate anti-tumor activity or improve treatment response.
Explore trials โFind Clinical Trials by Cancer Type
Different cancers require different trial strategies. Trial eligibility depends on diagnosis, stage, prior treatments, molecular profile, organ function, and overall fitness.
When Clinical Trials May Be Considered
Clinical trials are not suitable for every patient, but they may become important in specific situations. Patients often explore trials when standard treatments have stopped working, when the cancer has returned, when a rare mutation is found, or when advanced therapies are not available locally.
Clinical trial decisions should always be made carefully. The goal is not simply to find any trial, but to identify trials that match the patient's cancer biology, previous treatment history, current condition, and practical ability to travel or participate.
Patients may consider clinical trials when:
- Standard treatment options are limited
- Cancer has relapsed after previous treatment
- Disease is refractory to chemotherapy, immunotherapy, or targeted therapy
- A specific mutation or biomarker is present
- Advanced cell therapy or gene therapy is being explored
- Local options are unavailable or unaffordable
- A second opinion suggests investigational treatment may be appropriate
How CancerFax Helps You Explore Clinical Trial Options
CancerFax is not a general listing platform. We help patients and families make sense of clinical trial options with medical context, hospital coordination, and practical support โ reviewing diagnosis, treatment history, pathology, imaging, and molecular reports before suggesting whether a trial may be worth exploring.
Medical Report Review
We review diagnosis, stage, treatment history, pathology, scans, and molecular test reports before shortlisting trial options.
Trial Matching Support
We help identify trials based on cancer type, treatment history, mutation profile, country, and clinical condition.
Hospital Coordination
We communicate with hospitals, doctors, and trial teams to understand eligibility, availability, and next steps.
International Patient Support
For overseas trials, we assist with appointment coordination, documentation, travel planning, language support, and follow-up.
Realistic Guidance
We explain trial possibilities honestly, including eligibility limitations, timelines, risks, costs, and practical challenges.
Advanced Therapy Focus
CancerFax focuses strongly on advanced cancer treatments โ cell therapy, gene therapy, precision oncology, and investigational therapies.
Documents Needed to Check Clinical Trial Eligibility
Clinical trial eligibility depends on detailed medical information. To help evaluate whether a patient may qualify, the following reports are usually required.
Upload Reports for Trial Review โ- Latest medical summary
- Histopathology report
- Immunohistochemistry (IHC) report
- Molecular / NGS report, if available
- PET-CT, CT, or MRI reports
- Previous chemotherapy, immunotherapy, targeted therapy, or radiation details
- Surgery notes, if applicable
- Recent blood test reports
- Organ function reports
- Discharge summaries
- Current medication list
- Performance status, if available
Clinical Trial Eligibility Must Be Confirmed by the Treating Center
Clinical trial information on CancerFax is provided to help patients understand possible options. Final eligibility is always determined by the trial investigator, treating hospital, ethics committee, and applicable regulatory requirements.
A patient may appear suitable based on diagnosis but may still not qualify because of prior treatments, organ function, performance status, disease burden, infection status, blood counts, travel feasibility, or trial-specific criteria.
CancerFax helps patients explore options, but does not guarantee trial enrollment, treatment response, or clinical outcome.
Explore Cancer Clinical Trials by Country
Cancer trial availability varies by country. Some destinations may offer stronger access to specific treatment areas such as cell therapy, immunotherapy, targeted therapy, or mutation-specific trials.
Clinical Trials in China
One of the most active destinations for oncology trials, especially in cell therapy, CAR-T, CAR-NK, targeted therapy, and solid tumor research.
View trials โ
Clinical Trials in India
Growing access to oncology trials through major cancer centers, academic hospitals, and expanding precision oncology programs.
View trials โ
Clinical Trials in the USA
A large clinical trial ecosystem across academic cancer centers, pharmaceutical trials, and specialized research hospitals.
View trials โ
South Korea & Japan
Advanced oncology research, especially in immunotherapy, targeted therapy, and precision medicine programs.
View trials โ
Singapore & Southeast Asia
Singapore and selected Southeast Asian centers offer regional access to structured oncology research programs.
View trials โNot Sure Which Trial Is Right for You?
Many patients do not know which clinical trial to search for. That is completely understandable. Trial matching is complex and depends on many factors, including the cancer type, stage, prior treatments, genetic mutations, current health status, and location preference. Share your medical reports and our team will help assess whether any available trials may be worth exploring.
Request Clinical Trial Matching Support โClinical Trials, Briefly Explained
Direct answers to the questions patients and families ask most often when exploring trial options.
What are cancer clinical trials?
Cancer clinical trials are research studies that test new treatments, drug combinations, cell therapies, immunotherapies, targeted therapies, or diagnostic approaches in patients with cancer.
How can I find a cancer clinical trial?
You can search by cancer type, treatment, mutation, country, city, hospital, or trial phase. A medical report review is usually needed to confirm whether a trial may be suitable.
Can international patients join cancer clinical trials?
Some clinical trials accept international patients, but eligibility depends on the trial protocol, hospital policy, medical condition, travel feasibility, and follow-up requirements.
What documents are needed for clinical trial matching?
Patients usually need pathology reports, imaging reports, treatment history, molecular testing reports, blood tests, discharge summaries, and a current medical summary.
Questions Patients and Families Ask
Honest, clinically grounded answers to the most common questions we receive about cancer clinical trials.
Need Help Finding the Right Clinical Trial?
Finding a clinical trial can be difficult, especially when the cancer is advanced, relapsed, refractory, or mutation-driven. CancerFax helps patients and families review available options, understand eligibility requirements, and connect with appropriate hospitals or trial teams when suitable.